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The adenovirus L4-33K protein is a key regulator involved in the temporal shift from early to late
pattern of mRNA expression from the adenovirus major late transcription unit. L4-33K is a virus-
encoded alternative splicing factor, which enhances processing of 30 splice sites with a weak sequence
context. Here we show that L4-33K expressed from a plasmid is localized at the nuclear margin of
uninfected cells. During an infection L4-33K is relocalized to the periphery of E2A-72K containing viral
replication centers. We also show that serine 192 in the tiny RS repeat of the conserved carboxy-
terminus of L4-33K, which is critical for the splicing enhancer function of L4-33K, is necessary for the
nuclear localization and redistribution of the protein to viral replication sites. Collectively, our results
show a good correlation between the activity of L4-33K as a splicing enhancer protein and its
localization to the periphery of viral replication centers.
& 2012 Elsevier Inc. All rights reserved.Introduction
Adenovirus gene expression is subjected to a tight regulation
at both the transcriptional and post-transcriptional levels. Early
during the infectious cycle regulatory proteins are expressed that
reprogram the biosynthetic machineries of the host cell, resulting
in an almost exclusive production of the structural proteins
required for virus assembly at late times of infection. Essentially
all of the late structural proteins are encoded from the so-called
major late transcription unit (MLTU), which produces one
approximately 28,000 nucleotide-long pre-mRNA. This transcript
is polyadenylated at one of ﬁve possible sites, giving rise to ﬁve
families of mRNAs (L1–L5; Fig. 1A). Following the selection of the
poly(A) site, the transcript is alternatively spliced to produce
around 20 cytoplasmic mRNAs, all containing a common 201
nucleotide-long tripartite leader sequence at their 50-end
(reviewed in (Akusja¨rvi, 2008)).
The efﬁciency of poly(A) and 30 splice site selection is tempo-
rally regulated, producing only one mRNA, L1-52,55K, at early
times of infection (Akusja¨rvi and Persson, 1981; Nevins and
Wilson, 1981). At a transient stage soon after the onset of viral
replication, mRNAs from the L4 unit start to accumulate (Larsson,
Svensson, and Akusja¨rvi, 1992). The L4 unit encodes for fourll rights reserved.
stberg),
Persson),proteins whereof two, the L4-33K and L4-22K, are of interest for
this study. Previous work has shown that the L4-33K protein is a
key regulator of mRNA accumulation from the MLTU (Farley,
Brown, and Leppard, 2004), by functioning as a virus-encoded
alternative splicing factor (To¨rma¨nen et al., 2006). The L4-22K
protein appears to be a transcription factor that in combination
with the IVa2 protein activates transcription from the major late
promoter at the early to late transition (Backstro¨m et al., 2010;
Morris and Leppard, 2009). The L4-22K and L4-33K mRNAs differ
in that the L4-33K mRNA has an additional intron removed
(Fig. 1A). This splicing event causes a translational frame-shift
resulting in the production of two related proteins that share the
106 N-terminal amino acids, but have unique C-terminal ends.
L4-33K has a tiny RS-repeat in a region within the highly
conserved C-terminus, consisting of three RS and one SR motif
(Fig. 1B), which have been shown to be necessary for the splicing
enhancer function of L4-33K (To¨rma¨nen et al., 2006). This feature
makes L4-33K slightly resemble the family of serine–arginine rich
splicing factors (SR proteins), which are essential for the regula-
tion of constitutive and alternative splicing (Bourgeois, Lejeune,
and Stevenin, 2004; Shepard and Hertel, 2009). However, it
should be noted that L4-33K is not a classical SR protein, since
it does not contain a sufﬁciently large RS domain (Manley and
Krainer, 2010).
Splicing factors of the SR family exert their regulatory function
in splicing through their serine and arginine repeats in the RS
domain. The phosphorylation status of the RS domain governs the
nucleocytoplasmic shuttling of SR proteins (Cazalla et al., 2002;
Fig. 1. Schematic map of the MLTU. (A) Schematic representation of the major late transcription unit. The arrows show the different mRNAs from each family (L1–L5)
produced during infection. The blow-up shows the coding part of the L4-22K and L4-33K mRNAs including the functionally important ds region. (B) The L4-33K reading
frame with major elements and amino acid positions marked. The amino acid sequence of the ds region in the conserved C-terminus of L4-33K is shown expanded, with
the serine residues of interest marked. ss¼splice site; ds¼double splice.
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the further localization into discrete nuclear structures, the so-
called nuclear speckles or interchromatin granule clusters (IGCs)
(Caceres et al., 1997; Hedley, Amrein, and Maniatis, 1995; Li and
Bingham, 1991).
Since L4-33K has been shown to be a viral splicing factor with
a tiny RS-repeat needed for its function (To¨rma¨nen et al., 2006),
we decided to investigate whether the RS dipeptides were also
important for the function and subcellular localization of the
protein in vivo. Here we show that the wild type L4-33K protein
reorganizes efﬁciently into ring-like structures at E2A-72K con-
taining viral replication centers. These sites appear to correspond
to sites active in viral transcription. Further, we show that the so-
called ds region (Fig. 1), which encompasses the RS repeat, is
necessary but not sufﬁcient for the nuclear localization of L4-33K.
Also, we show that mutating serine 192 inhibits the splicing
enhancer activity of L4-33K in vivo, and results in a failure of the
protein to reorganize efﬁciently into the viral replication centers.Results
L4-33K does not localize to nuclear speckles
L4-33K is a virus-encoded alternative splicing factor, both neces-
sary and sufﬁcient for the activation of several late genes, most
prominently L1-IIIa (To¨rma¨nen et al., 2006). Because of its function as
a splicing factor, we decided to investigate whether it localizes to
IGCs along with other splicing factors, such as SRSF2 (Fu and
Maniatis, 1990; Spector, Fu, and Maniatis, 1991) in the absence of a
virus infection. For this experiment we transfected a FLAG-epitope
tagged L4-33K expressing plasmid into HEK293-cells and immunos-
tained with a monoclonal a-FLAG antibody. In summary, we
observed that L4-33K localizes almost exclusively to the cell nucleus(Fig. 2A) with the majority of cells showing a distinct enrichment of
L4-33K at the nuclear margin; a pattern that closely resembles that of
lamin B (Fig. 2D). It is also apparent that the pattern of FLAG-tagged
L4-33K protein is distinct from that of the SRSF2 staining (Fig. 2B),
demonstrating that L4-33K does not co-localize with IGCs in an
uninfected cell. Interestingly, more than half of all cells have several
cytoplasmic spots in close vicinity to the nucleus (Fig. 2). However
the nature of these spots is currently unknown.
Since L4-22K shares a large sequence with L4-33K (Fig. 1A) we
also investigated the subcellular distribution of this protein. As
shown in Fig. 2C, the pattern is distinct from that of L4-33K. The
L4-22K protein is also exclusively localized to the nucleus, but
lacks the pronounced accumulation at the nuclear margin and the
cytoplasmic spots observed with L4-33K.
Serines in the tiny RS repeat are important for localization
Since L4-33K and L4-22K both localized to the cell nucleus, it
appeared reasonable to suspect that a nuclear localization signal
might exist within the 106 amino acids of their identical
N-terminal parts. Thus, we decided to transfect cells with plasmids
expressing truncated L4-33K proteins to investigate whether
deletions in the N-terminus affected the subcellular localization,
using both indirect immunoﬂuorescence (Fig. 3A) and biochem-
ical fractionation (Fig. 3B).
The N-terminus of the L4-33K and L4-22K proteins is char-
acterized by an enrichment of acidic amino acids from residue
1–55 (Fig. 1B). However, deletion of this region did not affect the
nuclear membrane localization of L4-33K (Fig. 3). A further
deletion of the 106 N-terminal amino acids shared by L4-22K
and L4-33K still did not affect the subcellular distribution of the
protein. Taken together these results indicate that the two L4
proteins have distinct signals within their unique C-termini
directing their nuclear localization.
Fig. 2. Subcellular distribution of L4-22K and L4-33K in transfected HEK293 cells. HEK293 cells were transfected with FLAG epitope-tagged L4-33K or L4-22K constructs,
ﬁxed and immunostained 24 h post-transfection. Chromatin was visualized by DAPI staining (blue). (A) Representative immunostaining of wild type L4-33K (red).
(B) Co-staining of L4-33K (green) and SRSF2 (red). (C) Cell exhibiting the typical staining pattern of L4-22K (red). (D) Co-staining of L4-33K (red) and Lamin B (green). Scale
bar represents 10 mm.
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the conserved part of the carboxy-terminus (Fig. 1B) retained
much of the in vitro splicing enhancer phenotype of L4-33K
(To¨rma¨nen et al., 2006). As shown in Fig. 3A, this mutant
(D1–157) was still localized to the nucleus although the typical
association to the nuclear margin was disrupted.
The ds region is critical for the splicing enhancer phenotype of
L4-33K and contains the tiny RS-repeat with serines at position
176, 189, 192 and 196 (Fig. 1B). A common feature among
SR-proteins is that their RS-repeats are involved in both function
and localization (Caceres et al., 1997; Fu and Maniatis, 1990; Hedley,
Amrein, and Maniatis, 1995; Li and Bingham, 1991). Hence, we
decided to investigate whether the ds region, and especially the
tiny RS repeat, might be necessary for the nuclear localization of
L4-33K. For this experiment we transfected HEK293 cells with a
plasmid encoding an L4-33K mutant protein lacking the ds region,
and monitored the localization of the protein using both immu-
noﬂuorescence (Fig. 4A) and biochemical fractionation (Fig. 4B).
As shown in Fig. 4, removing the ds sequence resulted in a protein
that localized throughout the entire cell.
To determine what role the individual serines in the tiny RS
repeat might have on the nuclear localization of the protein, we
tested a collection of different L4-33K mutant proteins where the
serines in the RS repeat have been substituted for glycines. Three of
the mutant proteins did not differ in localization compared to the
wild type L4-33K protein, namely: S176G, S189G and S196G
(Fig. 4A). Interestingly, mutating the same three serine residues
does not have any adverse effects on the in vitro splicing enhancer
phenotype of L4-33K (To¨rma¨nen et al., 2006). In contrast, mutating
the serine at position 192 resulted in an approximate 50% redis-
tribution of the L4-33K protein to the cytoplasm (Fig. 4B). Impor-
tantly, this mutation blocks L4-33K as a splicing enhancer protein
both in vitro (To¨rma¨nen et al., 2006) and in vivo (see below, Fig. 6).
A triple mutation of serines 176, 189, and 196, which individually
did not affect the subcellular localization of L4-33K, increased the
cytoplasmic distribution (Fig. 4A) although the major fraction was
still predominantly located in the nucleus (Fig. 4B). This triple
mutant protein also showed a reduction in its capacity to function
as a splicing enhancer protein in vitro (To¨rma¨nen et al., 2006).
Collectively, these results suggest a good correlation between the
splicing enhancer phenotype of L4-33K and its nuclear distribution.
Mutations that abolish L4-33K as a splicing enhancer protein also
hinder the efﬁcient accumulation of the protein in the nucleus.
Splicing defective L4-33K mutant proteins do not relocalize to viral
replication centers
Previous studies have shown that during the late phase of
infection wild type L4-33K localizes in a ring-like pattern withinthe nucleus (Gambke and Deppert, 1981). To address whether
L4-33K, expressed from a plasmid, reorganized during a virus
infection and whether the tiny RS repeat was needed for this, we
performed a series of transient transfections with wild type or
mutant L4-33K constructs in 911 cells. Four hours post-
transfection cells were infected with wild type adenovirus 5
(Ad5), and 20 h post-infection cells were ﬁxed and permeabilized.
As before, we used an a-FLAG antibody to detect transfected
L4-33K protein expression. We also co-stained cells with an
antibody directed against the viral E2A-72K DNA-binding protein
in order to determine the infectious phase of each individual cell.
As shown in Fig. 5, the wild type L4-33K protein was efﬁciently
reorganized from the nuclear margin (Fig. 2A) to ring-like struc-
tures at late times of infection, in approximately 80% of the cells.
It was also apparent that these ring-like structures are at the
periphery of viral replication centers, as visualized by co-staining
with the E2A-72K antibody (Bosher, Dawson, and Hay, 1992;
Pombo et al., 1994; Puvion-Dutilleul and Puvion, 1990a; Puvion-
Dutilleul and Puvion, 1990b). The same reorganization was also
observed in HeLa cells (data not shown).
As expected from its function in gene expression, the FLAG-
tagged L4-22K also reorganized to the vicinity of the replication
centers (Fig. 5, compare with Fig. 2C) to the same extent as
L4-33K.
More than 80% of the L4-33K mutant proteins, S176G and
S196G, redistributed into these ring-like structures in contrast to
the splicing defective L4-33K mutant proteins, ds and S192G
(Fig. 5), where few, if any, cells showed a redistribution of the
proteins to replication centers. The L4-33K triple mutant protein,
SG176,189,196, which retain approximately 30% splicing enhan-
cer activity in vitro (To¨rma¨nen et al., 2006) accumulated with a
reduced efﬁciency to viral replication centers (approximately
30%), as did the S189G mutant protein (approximately 40%).
Collectively, these results suggest a connection between splicing
enhancer function of L4-33K and the nuclear reorganization to
viral ring-like structures.
Function and localization of L4-33K is not restored by replacing
serine 192 with the phosphomimetic aspartic acid
The phosphorylation status of serine residues in SR-proteins is
important for regulating both function and localization (Sanford
et al., 2005). In an attempt to investigate whether the phosphor-
ylation status of serine 192 is important for function and/or the
relocalization of L4-33K to the vicinity of viral replication centers,
serine 192 was exchanged for an aspartic acid creating the
mutant protein L4-33K S192D. The aspartic acid contributes
negative charge to amino acid 192, thus mimicking a phosphory-
lated serine residue. However, this mutant behaved essentially as
Fig. 3. Deletion mutants of L4-33K illustrate the lack of a nuclear localization signal within the ﬁrst 157 amino acids. HEK293-cells were transiently transfected with wild
type or deletion mutants of L4-33K-FLAG, and 24 h later the localization of the proteins were visualized by immunostaining or biochemical fractionation with subsequent
Western blotting. (A) Speciﬁc immunostaining of wild type (wt) L4-33K or N-terminal deletion mutants (D1–55, D1–106 or D1–157) (red) and chromatin (blue). Scale bar
represents 10 mm. (B) Western blot of the nuclear and cytoplasmic subcellular fractionations of cells transfected with 2 mg of wild type (wt) L4-33K or N-terminal deletion
mutant plasmids (D1–55 and D1–106).
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ently transfected cells (Fig. 6B) and a failure to relocalize to the
periphery of viral replication centers in infected cells (Fig. 6C).
This failure to redistribute to viral replication centers was also
recapitulated in functional assays. As shown in Fig. 6A, wild type
L4-33K efﬁciently activated the shift from L1–52,55K to L1-IIIa
alternative splicing (reviewed in (Akusja¨rvi, 2008)) in a transient
transfection assay. In contrast, both the S192G and the S192D
mutant proteins were severely impaired as activators of L1
alternative splicing. Collectively, these results suggest that serine
192 of the L4-33K protein is essential for function and offers thepossibility that the activity of the protein as a splicing enhancer
protein can be regulated by phosphorylation at this position (see
also Discussion).
The ds region is necessary but not sufﬁcient for the nuclear
localization of L4-33K
Since the ds region turned out to be necessary for an efﬁcient
nuclear localization of L4-33K (Fig. 4A), we decided to determine
whether it was also sufﬁcient. For this experiment wild type
L4-33K and the ds region were fused to the C-terminus of
Fig. 4. Serines in the RS-repeat are important for nuclear localization.
HEK293-cells were transiently transfected with plasmids expressing FLAG-
tagged wild type L4-33K or mutants and 24 h later subjected to immunostaining
or biochemical fractionation and subsequent Western blotting. (A) Speciﬁc
staining of L4-33K or mutant proteins (red) and chromatin (blue). Scale bar
corresponds to 10 mm. (B). Western blot of the nuclear (5 mg) and cyto-
plasmic (20 mg) subcellular fractionations of transfected cells. In the upper
panel, 0.1, 0.5, 1 or 2 mg wild type and ds mutant L4-33K plasmid have
been used, in the lower panel 0.1 or 2 mg of wild type and mutant L4-33K
plasmid have been used in transfections.
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transfected with the eGFP-L4-33K fusion plasmids, and the loca-
tion of these proteins was visualized in a ﬂuorescence micro-
scope. As seen in Fig. 7A, fusion of the full length L4-33K protein
to eGFP (eGFP-L4-33K) resulted in an almost exclusive nuclear
localization of the protein whereas the untagged eGFP protein
(eGFP) showed a uniform cellular distribution. Small cytoplasmic
spots, as seen in our previous transfections (Fig. 4), were also
evident in eGFP-L4-33K transfected cells. However, it was difﬁcult
to conclude whether the eGFP-L4-33K protein had an enriched
accumulation at the nuclear margin as seen with the FLAG-tagged
protein. Interestingly, the ds fusion protein (eGFP-ds) was evenly
diffused throughout the whole cell.
In order to test whether the ds region was sufﬁcient for
targeting L4-33K into the ring-like structures, 911 cells were
simultaneously transfected with the eGFP fusion proteins and
infected with wild type Ad5. As shown in Fig. 7B, the eGFP-L4-33K
protein was efﬁciently distributed into the ring-like structures in
95% of the cells. However, the eGFP-ds protein failed to do so and
remained equably distributed within the cell.
Taken together our results suggest that the ds region is
necessary but not sufﬁcient for both nuclear localization of
L4-33K and its re-localization to E2A-72K containing replication
centers late during infection.Discussion
Here we demonstrate that L4-33K, which shows an association
with the nuclear margin when expressed alone, reorganizes into
E2A-72K containing viral replication centers during a wild type
Ad5 infection. We also demonstrate that particular serine resi-
dues within a tiny RS-repeat in the C-terminus of the L4-33K
protein (Fig. 1B) are important both for the nuclear localization
and the redistribution of L4-33K in the late phase of infection,
with serine 192 being crucial for this activity.
During adenoviral replication, the nucleus undergoes a dra-
matic restructuring. Replicative foci emerge with zones of actively
replicating genomes associated with E2A-72K, bordered by pools
of viral ssDNA and nascent viral mRNA (Pombo et al., 1994).
At late times of infection, the splicing factor containing IGCs are
rearranged from the speckled pattern seen in uninfected cells to
the surroundings of ring-like structures that have been desig-
nated the viral replication centers. The immediate surroundings
of the E2A-72K labeled replication centers have been shown to be
sites of viral transcription (Aspegren, Rabino, and Bridge, 1998;
Pombo et al., 1994), and both snRNPs and SRSF1 (Aspegren,
Rabino, and Bridge, 1998; Gama-Carvalho, Condado, and Carmo-
Fonseca, 2003; Pombo et al., 1994) are reorganized into these
sites during an adenovirus infection.
Interestingly, when L4-33K transfected cells were infected
with wild type Ad5, L4-33K redistributed from its site of accu-
mulation at the nuclear margin into ring-like structures in the
nucleoplasm (Fig. 5). The accumulation into the ring-like pattern
does not occur at early times of infection, when the transfected
L4-33K protein localizes primarily in close proximity to the
nuclear membrane (data not shown) similarly to what was
observed in non-infected cells (Fig. 2). Co-staining for the E2A-
72K DNA binding protein demonstrated that L4-33K is closely
associated with the E2A-72K protein (Fig. 5) in the periphery of
viral replication centers.
As the infectious cycle proceeds, the splicing factors around
the replication centers are displaced and constricted to the
periphery of the nucleus at a time that seems to correlate
with the switch from the early to late phase of gene express-
ion (Aspegren, Rabino, and Bridge, 1998; Bridge et al., 2003;
Fig. 5. Serines in the tiny RS-repeat are important for reorganization of L4-33K during a wild type Ad5 infection. 911-cells were transfected with plasmids expressing
FLAG-tagged wild type L4-33K or mutants and subsequently infected with Ad5. 20 h post infection cells were ﬁxed and immunostained for FLAG-tagged proteins (red) and
viral E2A-72K (green), respectively. Chromatin was visualized by DAPI staining (blue). Scale bar represents 10 mm.
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2010). In adenovirus-infected cells, SRSF1 has been shown to be
inactivated at late times of infection through a virus-induced SRprotein dephosphorylation (Kanopka et al., 1998). The viral
E4-ORF4, which binds the cellular protein phosphatase 2A, aids
in the activation of the early to late shift in L1 alternative splicing
Fig. 6. Substitution of serine 192 with aspartic acid changes both function and localization of L4-33K. (A) 10 mg of cytoplasmic RNA from HEK293-cells transfected with
pTripL1,L2 reporter plasmid alone (–) or together with either wild type L4-33K, L4-33K S192G or L4-33K S192D expressing plasmids were analyzed in an S1 protection
assay. 0.5 mg of cytoplasmic RNA from HEK293-cells infected with Ad5 were used as a positive control (inf). (B) 911 cells were transiently transfected with L4-33K S192D
plasmid, ﬁxed and immunostained for the mutant protein (red). Chromatin was stained by DAPI (blue). (C) 911 cells were transfected as above and subsequently infected
with Ad5. 20 h post infection cells were ﬁxed and immunostained for L4-33K S192D (red) and the viral E2–72K DNA binding protein (green). Scale bar represents 10 mm.
Fig. 7. The ds region is not sufﬁcient for nuclear localization or subnuclear reorganization of L4-33K. (A) HEK293-cells were transiently transfected with plasmids
expressing eGFP fusion proteins and 24 h later ﬁxed and examined by ﬂuorescence microscopy. DAPI-stained chromatin shown in blue and eGFP fusion proteins in green.
(B) 911 cells were transfected as above, four hours later infected with Ad5 and 20 h post infection ﬁxed and immunostained for the presence of viral E2A-72K (red). DAPI-
staining of chromatin is visualized in blue and eGFP fusion proteins in green. Scale bar represents 10 mm.
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2001). Interestingly, a virus lacking the entire E4 region fails to
reorganize splicing factors into enlarged IGCs (Bridge et al., 2003).
Although E4-ORF4 clearly plays a regulatory role in RNA splicing
our results show that the L4-33K protein is the key regulator of L1
alternative splicing. Thus, expression of this protein alone appears
to be sufﬁcient to convert an uninfected HeLa cell to a cell that
splices the L1 unit almost identically to what we observe in an
adenovirus-infected cell (To¨rma¨nen et al., 2006).
In contrast to the aforementioned cellular splicing factors,
L4-33K becomes concentrated around the viral replication centers
at late times of infection. Taken together, these results may
suggest that adenovirus displaces cellular splicing factors from
sites of viral gene expression to make more efﬁcient use of its
own virus-encoded counterparts. With a reorganization of L4-33K
to sites of active viral gene expression, this could lead to an
increase in the usage of many, if not all, alternative 30 splice sites
in the MLTU, thereby contributing to the temporal shift from the
early to the late phase of gene expression.
Notably, deleting the ds region or mutating serine 192 in
L4-33K resulted in proteins that failed to relocalize to the viral
replication centers in Ad5-infected cells, arguing for a function ofthe tiny RS repeat in the assembly of a functional viral replication
machinery. This is a property that strengthens the notion that
L4-33K has functional similarity to members of the SR family of
splicing regulatory factors. However, the ds region is necessary
but not sufﬁcient for the exclusive nuclear localization of L4-33K
(Fig. 7), indicating that there might be a more complex nuclear
localization signal in the protein. The single S189G mutant and
the triple mutant (SG176,189,196) showed a partial reorganiza-
tion to the ring-like structures, indicating that multiple serines
within the ds region contribute to this phenotype.
To the best of our knowledge there is only one other protein
that has a tiny RS repeat, which has been associated with
function. Thus, the lamin B receptor has a short RS repeat (four
RS dipeptides in humans) that appears to be important for
function. Modeling experiments have shown that phosphoryla-
tion of this short RS repeat induces a conformational change that
appears to be necessary for lamin B receptor binding to histone
H3 (Sellis et al., 2012).
It is noteworthy that our results show a surprisingly good
correlation between the function of L4-33K as a splicing enhancer
protein and the capacity of the protein to localize to the nucleus
and reorganize into viral transcription sites in late virus-infected
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tion of the protein (ds and S192G; Fig. 4), also drastically reduce
the splicing enhancer function in vitro (To¨rma¨nen et al., 2006).
This ﬁnding is particularly intriguing since the functional assays
were done by supplementing nuclear extracts prepared from
uninfected HeLa cells with a recombinant L4-33K protein. Collec-
tively, these results suggest a possible link between assembly of
the viral replication centers and the recruitment of the spliceo-
some to the complex, a possibility that is in need of experimental
veriﬁcation.
L4-33K is one of the major phosphorylated proteins expressed
in adenovirus-infected cells (Axelrod, 1978). We have recently
shown that two cellular protein kinases that phosphorylate
L4-33K have opposite effects on L1 alternative splicing (To¨rma¨nen
Persson et al., 2012): cAMP dependent protein kinase (PKA)
activates whereas the DNA-dependent protein kinase (DNA-PK)
inhibits the temporal switch in adenovirus L1 alternative splicing.
Of speciﬁc interest for this study is that DNA-PK was shown to
phosphorylate residues within the L4-33K ds region (Fig. 1B).
Since serine 192 is located within this region and plays a critical
role for the function of L4-33K protein as a splicing enhancer
protein (To¨rma¨nen et al., 2006), we tested the possibility that
DNA-PK phosphorylation of serine 192 might explain the inhibi-
tory effect of DNA-PK on the L4-33K splicing enhancer activity. To
do this we replaced serine 192 with an aspartic acid, producing
the phosphomimetic mutant S192D. As shown in Fig. 6, this
mutant protein did not relocalize efﬁciently to the nucleus or viral
replication centers during infection and further the mutation
inactivated the protein as an L1 alternative splicing factor. This
ﬁnding would be consistent with the hypothesis that DNA-PK
phosphorylation of serine 192 would be inhibitory for L4-33K
function. Although attractive as a working model we realize that
there are multiple alternative explanations for the failure of
mutant S192D to localize correctly to viral replication centers
and function as an L1 alternative splicing factor. For example,
serine 192 might have to undergo cycles of phosphorylation and
dephosphorylation. The net charge of a phosphorylated serine
192 might not be the only parameter important for function. Also,
we do not currently know that serine 192 is phosphorylated.
Thus, amino acid 192 might have to be a serine and any mutation
might therefore disturb function. Clearly, a key challenge for our
future work is to identify the phosphorylated amino acids in
L4-33K, and establish their signiﬁcance for the function of the
protein as an alternative RNA splicing factor. Experiments are in
progress to resolve questions like these.Material and methods
Plasmids
The pcDNA3-L4-33K and pcDNA3-L4-22K plasmids encode for
cDNA versions of the L4-33K and L4-22K proteins with a C-
terminal FLAG-epitope tag and have previously been described
(Backstro¨m et al., 2010). The ds and SG mutants previously
described (To¨rma¨nen et al., 2006) were recloned into pcDNA3-
L4-33K by transfer of an AfeI-XhoI restriction fragment from the
previously described pet24a constructs (To¨rma¨nen et al., 2006).
The S192D mutant was generated by PCR using oligonucleotides
containing the desired nucleotide changes. All L4-33K proteins
contain a carboxy-terminal FLAG-epitope tag for easy detection
with the monoclonal M2 anti-FLAG antibody. The peGFP-L4-33K
plasmid was constructed by transferring a KpnI-XbaI fragment
from pcDNA3-L4-33K (encoding the entire L4-33K reading frame)
to peGFP-C1 (Clontech), resulting in a plasmid expressing L4-33K
as a carboxy-terminal fusion to eGFP. The peGFP-ds plasmid wasdesigned by inserting a synthetic, overlapping oligonucleotide
pair (corresponding to amino acids 170–197 of L4-33K) as a KpnI-
XbaI fragment into peGFP-C1. The pTripL1,L2 plasmid has been
previously described (Svensson and Akusja¨rvi, 1985) and so has
the pAdCMV-IIIa plasmid (Kanopka, Mu¨hlemann, and Akusja¨rvi,
1996). Details about cloning strategies, plasmid maps and
sequences are available upon request.
Transient transfections
Human embryonic kidney (HEK) 293 cells were grown on
60-mm or 24-well plates in Dulbecco’s modiﬁed Eagle’s medium
(Invitrogen), supplemented with 10% newborn calf serum, and
100 units/ml penicillin–streptomycin (Invitrogen). Subconﬂuent
cells were transfected using the calcium phosphate co-precipitation
method (Ausubel et al., 1995) or the Turbofect method according
to manufacturers protocol (Fermentas). In western blot experi-
ments, 60-mm plates were transfected with 0.1, 1 or 2 mg of the
effector plasmid. The total amount of DNA was brought to 2 or
4 mg by addition of the empty pcDNA3 vector. In immunoﬂuor-
escence experiments 0.1 mg effector plasmid and 0.9 mg of empty
pcDNA3 vector DNA was mixed and transfected to 24-well plates.
Infections
911 cells were grown on cover slips and transfected as
described above. 4 h post-transfection, cells were infected with
wild type Ad5 at a multiplicity of 20 FFU/cell. 20 h post infection
cells were immunostained and analyzed as described below.
Indirect immunoﬂuorescence staining
HEK293, 911 or HeLa cells were grown on poly-L-lysine and/or
ﬁbronectin coated glass cover slips to subconﬂuence and then
transfected as described above. Cells were washed twice in PBS
(13.8 mM NaCl, 0.27 mM KCl, 0.8 mM Na2HPO4 and KH2PO4, pH
7.4), ﬁxed with 3% paraformaldehyde in PBS (pH 7.2–7.6) for
15 min and permeabilized with 0.1% Triton X-100 in PBS-T (0.01%
Tween 20 in PBS) for 15 min. Cells were blocked with PBS-T/BSA
(2% bovine serum albumin in PBS-T) for 30 min. Primary anti-
bodies were diluted in PBS-T/BSA, as follows: monoclonal mouse
a-FLAG M2 1:1000 (Sigma-Aldrich), polyclonal rabbit a-FLAG
1:250 (Sigma-Aldrich), monoclonal mouse a-SFRS 1:1000
(Sigma-Aldrich), polyclonal rabbit a-lamin B 1:700 (Abcam),
polyclonal rabbit a–E2A-72K 1:1000 (kindly provided by Bruce
Stillman). Secondary antibodies used were a-mouse IgG TRITC
conjugate (Sigma) or a-rabbit FITC conjugate (Sigma), diluted
1:1000 in PBS-T/BSA. Antibodies were applied for 1 h and all
procedures were performed at room temperature. Cover slips
were mounted with Fluoromount-G mounting media (Southern
Biotech) supplemented with DAPI (ﬁnal concentration 1 mg/ml)
on glass slides. Non-infected cells containing eGFP constructs
were mounted directly after permeabilization. Cells were visua-
lized by a ﬂuorescence microscope (Nikon eclipse 90i) and
pictures captured by NIS-elements (AR 3.10, Nikon) software.
Subcellular fractionation
Transfected cells were washed twice in PBS, lysed in IsoB-
NP40 (10 mM Tris-HCl [pH 7.9], 0.15 M NaCl, 1.5 mM MgCl2, 0.5%
Nonidet P-40 supplemented with protease inhibitor complete
mini EDTA-free [Roche]) and the cytoplasmic protein fraction
was cleared by centrifugation. The remaining pellet was mixed
with RIPA buffer (20 mM K-PO4, 0.1% SDS, 1% Triton-X 100, 0.5%
deoxycholate, 0.1 M NaCl, supplemented with protease inhibitor
complete mini EDTA-free [Roche]) and disrupted by sonication
S. O¨stberg et al. / Virology 433 (2012) 273–281 281(105 s, low output, Biorupter UCD300, Diagenode) and the
nuclear protein fraction was cleared by centrifugation.
Western blot analysis
Cytoplasmic and nuclear protein fractions were denatured in
Laemmli sample buffer (60 mM Tris-HCl [pH 6.8], 2% SDS, 10%
glycerol, 5% b-mercaptoethanol, 0.01% bromophenol blue). The
cytoplasmic (2.5% or 20 mg) and nuclear (4% or 5 mg) fractions
were separated on a 12% SDS-PAGE gel and transferred to a
nitrocellulose ﬁlter by electroblotting. Membranes were blocked
in TBS-T (50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 0.2% Tween 20)
with 5% dry milk and incubated with primary antibody (mono-
clonal mouse a-FLAG M2, Sigma-Aldrich) diluted 1:1000 in TBS-T
with 2% dry milk, for 1 h. After washing with TBS-T, membranes
were incubated with secondary antibody (rabbit a-mouse anti-
body conjugated to horseradish peroxidase [HRP; DAKO]) diluted
1:5000 in TBS-T with 2% dry milk, for 1 h. Membranes were ﬁnally
washed with TBS-T, and proteins were visualized by chemilumi-
nescence with the ECL Western blot reagent as described by the
manufacturer (Amersham Bioscience).
S1 nuclease protection assay
Cells were washed twice in PBS, lysed in isoB/NP40 (0.5%) and
total cytoplasmic RNA was isolated by phenol–chloroform extrac-
tion. The DNA probe was prepared by 50-end radioactive labeling
of pAdCMV-IIIa cut with MluI for detection of L1 mRNAs
(Backstro¨m et al., 2010). A total of 10 mg of cytoplasmic RNA
was analyzed and resolved on an 8% denaturing polyacrylamide
gel. The hybridization temperature was 55 1C. General conditions
of the S1 analysis have previously been described (Svensson,
Pettersson, and Akusja¨rvi, 1983).Acknowledgments
We would like to thank Ellenor Backstro¨m Winquist for con-
tributions during the initial phase of this project. We are also
grateful to Bruce Stillman for the kind gift of the E2A-72K antibody.
The research presented here was made possible by generous grants
from The Swedish Cancer Society, EURASNET and the Uppsala RNA
Research Centre.
References
Akusja¨rvi, G., 2008. Temporal regulation of adenovirus major late alternative RNA
splicing. Front Biosci. 13, 5006–5015.
Akusja¨rvi, G., Persson, H., 1981. Controls of RNA splicing and termination in the
major late adenovirus transcription unit. Nature 292, 420–426.
Aspegren, A., Rabino, C., Bridge, E., 1998. Organization of splicing factors in
adenovirus-infected cells reﬂects changes in gene expression during the early
to late phase transition. Exp. Cell Res. 245, 203–213.
Ausubel, F.M., Brent, R., Kingston, R.E., Moore, D.D., Seidman, J.G., Smith, J.A.,
Struhl, K., 1995. In: Janssen, K. (Ed.), Current protocols in molecular biology.
John Wiley and sons, Inc., Boston.
Axelrod, N., 1978. Phosphoproteins of adenovirus 2. Virology 87, 366–383.
Backstro¨m, E., Kaufmann, K.B., Lan, X., Akusja¨rvi, G., 2010. Adenovirus L4-22K
stimulates major late transcription by a mechanism requiring the intragenic
late-speciﬁc transcription factor-binding site. Virus Res. 151, 220–228.
Bosher, J., Dawson, A., Hay, R.T., 1992. Nuclear factor I is speciﬁcally targeted to discrete
subnuclear sites in adenovirus type 2-infected cells. J. Virol. 66, 3140–3150.
Bourgeois, C.F., Lejeune, F., Stevenin, J., 2004. Broad speciﬁcity of SR (serine/
arginine) proteins in the regulation of alternative splicing of pre-messenger
RNA. Prog. Nucleic Acid Res. Mol. Biol. 78, 37–88.Bridge, E., Mattsson, K., Aspegren, A., Sengupta, A., 2003. Adenovirus early region
4 promotes the localization of splicing factors and viral RNA in late-phase
interchromatin granule clusters. Virology 311, 40–50.
Caceres, J.F., Misteli, T., Screaton, G.R., Spector, D.L., Krainer, A.R., 1997. Role of the
modular domains of SR proteins in subnuclear localization and alternative
splicing speciﬁcity. J. Cell Biol. 138, 225–238.
Cazalla, D., Zhu, J., Manche, L., Huber, E., Krainer, A.R., Caceres, J.F., 2002. Nuclear
export and retention signals in the RS domain of SR proteins. Mol. Cell Biol. 22,
6871–6882.
Estmer Nilsson, C., Petersen-Mahrt, S., Durot, C., Shtrichman, R., Krainer, A.R.,
Kleinberger, T., Akusja¨rvi, G., 2001. The adenovirus E4-ORF4 splicing enhancer
protein interacts with a subset of phosphorylated SR proteins. EMBO J. 20,
864–871.
Farley, D.C., Brown, J.L., Leppard, K.N., 2004. Activation of the early-late switch in
adenovirus type 5 major late transcription unit expression by L4 gene
products. J. Virol. 78, 1782–1791.
Fu, X.D., Maniatis, T., 1990. Factor required for mammalian spliceosome assembly
is localized to discrete regions in the nucleus. Nature 343, 437–441.
Gama-Carvalho, M., Condado, I., Carmo-Fonseca, M., 2003. Regulation of adeno-
virus alternative RNA splicing correlates with a reorganization of splicing
factors in the nucleus. Exp. Cell Res. 289, 77–85.
Gambke, C., Deppert, W., 1981. Late nonstructural 100,000- and 33,000-dalton
proteins of adenovirus type 2. I. Subcellular localization during the course of
infection. J. Virol. 40, 585–593.
Hedley, M.L., Amrein, H., Maniatis, T., 1995. An amino acid sequence motif
sufﬁcient for subnuclear localization of an arginine/serine-rich splicing factor.
Proc. Natl. Acad. Sci. U S A 92, 11524–11528.
James, N.J., Howell, G.J., Walker, J.H., Blair, G.E., 2010. The role of Cajal bodies in the
expression of late phase adenovirus proteins. Virology 399, 299–311.
Kanopka, A., Mu¨hlemann, O., Akusja¨rvi, G., 1996. Inhibition by SR proteins of
splicing of a regulated adenovirus pre-mRNA. Nature 381, 535–538.
Kanopka, A., Mu¨hlemann, O., Petersen-Mahrt, S., Estmer, C., O¨hrmalm, C.,
Akusja¨rvi, G., 1998. Regulation of adenovirus alternative RNA splicing by
dephosphorylation of SR proteins. Nature 393, 185–187.
Kataoka, N., Bachorik, J.L., Dreyfuss, G., 1999. Transportin-SR, a nuclear import
receptor for SR proteins. J. Cell Biol. 145, 1145–1152.
Larsson, S., Svensson, C., Akusja¨rvi, G., 1992. Control of adenovirus major late gene
expression at multiple levels. J. Mol. Biol. 225, 287–298.
Li, H., Bingham, P.M., 1991. Arginine/serine-rich domains of the su(wa) and tra
RNA processing regulators target proteins to a subnuclear compartment
implicated in splicing. Cell 67, 335–342.
Manley, J.L., Krainer, A.R., 2010. A rational nomenclature for serine/arginine-rich
protein splicing factors (SR proteins). Genes Dev. 24, 1073–1074.
Morris, S.J., Leppard, K.N., 2009. Adenovirus serotype 5 L4-22K and L4-33K
proteins have distinct functions in regulating late gene expression. J. Virol.
83, 3049–3058.
Nevins, J.R., Wilson, M.C., 1981. Regulation of adenovirus-2 gene expression at
the level of transcriptional termination and RNA processing. Nature 290,
113–118.
Pombo, A., Ferreira, J., Bridge, E., Carmo-Fonseca, M., 1994. Adenovirus replication
and transcription sites are spatially separated in the nucleus of infected cells.
EMBO J. 13, 5075–5085.
Puvion-Dutilleul, F., Puvion, E., 1990a. Analysis by in situ hybridization and
autoradiography of sites of replication and storage of single- and double-
stranded adenovirus type 5 DNA in lytically infected HeLa cells. J. Struct. Biol.
103, 280–289.
Puvion-Dutilleul, F., Puvion, E., 1990b. Replicating single-stranded adenovirus type
5 DNA molecules accumulate within well-delimited intranuclear areas of
lytically infected HeLa cells. Eur. J. Cell Biol. 52, 379–388.
Sanford, J.R., Ellis, J.D., Cazalla, D., Caceres, J.F., 2005. Reversible phosphorylation
differentially affects nuclear and cytoplasmic functions of splicing factor
2/alternative splicing factor. Proc. Natl. Acad. Sci. U S A 102, 15042–15047.
Sellis, D., Drosou, V., Vlachakis, D., Voukkalis, N., Giannakouros, T., Vlassi, M., 2012.
Phosphorylation of the arginine/serine repeats of lamin B receptor by SRPK1-
insights from molecular dynamics simulations. Biochim. Biophys. Acta 1820,
44–55.
Shepard, P.J., Hertel, K.J., 2009. The SR protein family. Genome Biol. 10, 242.
Spector, D.L., Fu, X.D., Maniatis, T., 1991. Associations between distinct pre-mRNA
splicing components and the cell nucleus. EMBO J. 10, 3467–3481.
Svensson, C., Akusja¨rvi, G., 1985. Adenovirus VA RNAI mediates a translational
stimulation which is not restricted to the viral mRNAs 4, 957–964EMBO J. 4,
957–964.
Svensson, C., Pettersson, U., Akusja¨rvi, G., 1983. Splicing of adenovirus 2 early
region 1A mRNAs is non-sequential. J. Mol. Biol. 165, 475–495.
To¨rma¨nen, H., Backstro¨m, E., Carlsson, A., Akusja¨rvi, G., 2006. L4-33K, an
adenovirus-encoded alternative RNA splicing factor. J. Biol. Chem. 281,
36510–36517.
To¨rma¨nen Persson, H., Aksaas, A.K., Kvissel, A.K., Punga, T., Engstro¨m, A˚., Ska˚lhegg,
B.S., Akusja¨rvi, G., 2012. Two cellular protein kinases, DNA-PK and PKA,
phosphorylate the adenoviral L4-33K protein and have opposite effects on
L1 alternative RNA splicing. PLoS One 7, e31871.
